Hunan Fangsheng Pharmaceutical Co., Ltd. (SHA:603998)

China · Delayed Price · Currency is CNY

10.43

+0.29 (2.86%)

Aug 20, 2026, 3:00 PM CST

-9.38% (1Y)

Market Cap	4.58B -9.4%
Revenue (ttm)	1.79B +1.9%
Net Income	306.52M +12.2%
EPS	0.70 +12.9%
Shares Out	439.08M
PE Ratio	14.90
Forward PE	12.57
Dividend	0.45 (4.34%)
Ex-Dividend Date	May 29, 2026

Volume	22,634,400
Open	10.34
Previous Close	10.14
Day's Range	10.26 - 10.56
52-Week Range	8.64 - 13.50
Beta	0.26
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 29, 2026

About SHA:603998

Hunan Fangsheng Pharmaceutical Co., Ltd. engages in research, develops, produces, and sells traditional Chinese medicine industry and chemical pharmaceutical products in China. The company offers pharmaceutical manufacturing; and provides cardiovascular and cerebrovascular drugs, skeletal muscle system drugs, orthopedic drugs, respiratory drugs, pediatric drugs, neurological drugs, gynecological drugs, and anti-infective drugs. Its products include Xuesaitong dispersible tablets; Xuesaitong tablets; Garcinia Cambogia bone strengthening tablets;... [Read more]

Industry Drug Manufacturers - Specialty & Generic

Sector Healthcare

Founded 2000

Employees 1,868

Stock Exchange Shanghai Stock Exchange

Ticker Symbol 603998

Full Company Profile

Financial Performance

In 2025, SHA:603998's revenue was 1.75 billion, a decrease of -1.75% compared to the previous year's 1.78 billion. Earnings were 306.39 million, an increase of 20.05%.

Financial Statements